20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in normal renal function
HD                     :Unlikely to be dialysed. Dose as in normal renal function
HDF/high flux   :Unknown dialysed. Dose as in normal renal function
CAV/VVHD      :Unknown dialysability. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnaesthetics: risk of arrhythmias with volatile liquid anaesthetics such as halothaneAntidepressants: hypertensive crisis with MAOIs and linezolid (including moclobemide) – avoid for at least 2 weeks after stopping MAOIBupropion: increased risk of side effects of levodopaFerrous sulphate: reduces AUC of levodopa by 30–50%, clinically significant in some but not all patients
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
OTHER INFORMATION
Can be used to treat restless legs syndrome at a dose of 62.5–125 mgUrine may be red-tinged and turn dark on standing, due to metabolitesSerum uric acid and blood urea nitrogen levels are occasionally elevated